Introduction
Diabetic foot ulceration (DFU) is a common disability burden, with a 25% lifetime risk in persons with diabetes [1]; it is estimated that 40 to 60 million people are glob ally affected by DFU [2]. The condition has an important impact on quality of life of both persons with diabetes and DFU and their informal caregivers [3, 4] and causes substantial healthcare costs [2, 5, 6]. Because of the sig nificant physical, psychosocial and economic impact of diabetic foot disease, there is a global search by the medical community for systems of quality evaluation and